SERA-SCANDIA A/S: Financial statements 2013
CVR: 14605185
Source: annual report 2013, Danish Business Authority
01/04/2012 – 31/03/2013
SERA-SCANDIA A/S (CVR 14605185) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 0 and a net result of DKK -8,816,471. Equity in the 2013 report amounted to DKK 36,193,129. The solvency ratio was 51.2%.
- Revenue
- DKK 0
- Gross Profit
- DKK 0
- Profit/Loss
- DKK -8,816,471
- Equity
- DKK 36,193,129
- Total Assets
- DKK 70,665,349
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationAbout SERA-SCANDIA A/S
SERA-SCANDIA A/S is a Danish company of the type Aktieselskab based in Ballerup, founded in 1990. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named SERA-SCANDIA ApS and VICH 2604 ApS. The management consists of Troels Zakarias Glahn Kristiansen. The board consists of Ole Bødtker Nielsen (chair), Christian Lykkehus Sørensen and Nicolas Bødtker Nielsen. The company is owned by Danbiotech Inc.. The company has 16 employees (2026). In 2025, the company reported a gross profit of DKK 40,586,000 and a net result of DKK -7,801,000 compared with DKK 2,203,000 the year before. Equity in the 2025 report amounted to DKK 272,104,000.